USFDA conducts inspection of Sun Pharma’s Halol site: Sources

The USFDA inspection at Halol in 2015 had resulted in 23 observations – a set of deficiencies in the manufacturing processes.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2PaCQVQ
via IFTTT